As of 2025-05-15, the EV/EBITDA ratio of Moderna Inc (MRNA) is -2.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 7,726.61 mil USD. MRNA's TTM EBITDA according to its financial statements is -3,079.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 15.1x | 12.8x |
| Forward P/E multiples | 7.1x - 12.5x | 9.8x |
| Fair Price | (85.80) - (95.83) | (85.96) |
| Upside | -457.2% - -499.0% | -457.9% |
| Date | EV/EBITDA |
| 2025-05-14 | -2.51 |
| 2025-05-13 | -2.69 |
| 2025-05-12 | -2.72 |
| 2025-05-09 | -2.54 |
| 2025-05-08 | -2.55 |
| 2025-05-07 | -2.51 |
| 2025-05-06 | -2.56 |
| 2025-05-05 | -2.99 |
| 2025-05-02 | -2.96 |
| 2025-05-01 | -2.89 |
| 2025-04-30 | -3.08 |
| 2025-04-29 | -2.99 |
| 2025-04-28 | -2.94 |
| 2025-04-25 | -2.91 |
| 2025-04-24 | -2.93 |
| 2025-04-23 | -2.83 |
| 2025-04-22 | -2.73 |
| 2025-04-21 | -2.65 |
| 2025-04-17 | -2.60 |
| 2025-04-16 | -2.66 |
| 2025-04-15 | -2.79 |
| 2025-04-14 | -2.86 |
| 2025-04-11 | -2.78 |
| 2025-04-10 | -2.57 |
| 2025-04-09 | -2.84 |
| 2025-04-08 | -2.59 |
| 2025-04-07 | -2.71 |
| 2025-04-04 | -2.65 |
| 2025-04-03 | -2.72 |
| 2025-04-02 | -2.97 |
| 2025-04-01 | -2.90 |
| 2025-03-31 | -3.05 |
| 2025-03-28 | -3.40 |
| 2025-03-27 | -3.53 |
| 2025-03-26 | -3.45 |
| 2025-03-25 | -3.74 |
| 2025-03-24 | -3.78 |
| 2025-03-21 | -3.59 |
| 2025-03-20 | -3.57 |
| 2025-03-19 | -3.68 |
| 2025-03-18 | -3.74 |
| 2025-03-17 | -3.85 |
| 2025-03-14 | -3.84 |
| 2025-03-13 | -3.80 |
| 2025-03-12 | -3.89 |
| 2025-03-11 | -3.73 |
| 2025-03-10 | -4.01 |
| 2025-03-07 | -3.96 |
| 2025-03-06 | -3.80 |
| 2025-03-05 | -3.91 |